Petros Pharmaceuticals to Present at the Planet MicroCap Showcase 2022
Petros Pharmaceuticals (Nasdaq: PTPI) announces its President and Chief Commercial Officer, Fady Boctor, will present at the Planet MicroCap Showcase 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Petros Pharmaceuticals (Nasdaq: PTPI) announces its President and Chief Commercial Officer, Fady Boctor, will present at the Planet MicroCap Showcase 2022. The event takes place from May 3-5, 2022, at Bally’s Hotel & Casino, Las Vegas, NV, with Boctor's presentation scheduled for May 4 at 10:00 AM PT. He will also be available for one-on-one meetings during the conference. Petros focuses on innovative therapies for men’s health, targeting issues like erectile dysfunction and hormone health.
Details
News Market Reaction – PTPI
The recorded move for PTPI in the trading session of this news was +0.88%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces today that President and Chief Commercial Officer Fady Boctor will present virtually at the Planet MicroCap Showcase 2022. The conference is being held on May 3 – 5, 2022 at The Bally’s Hotel & Casino in Las Vegas, NV.
| Presentation Date: | May 4, 2022 |
| Time: | 10:00am Pacific Time |
| Webcast Link: | https://www.webcaster4.com/Webcast/Page/2862/45053 |
Mr. Boctor will be available for one-on-one meetings. To request a meeting and to register for the conference, click here: https://planetmicrocapshowcase.com/signup
About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.
CONTACTS:
Jules Abraham
CORE IR
917-885-7378
pr@coreir.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.